A phase II trial of cisplatin in early stage ER [estrogen receptor]-, PR [progesterone receptor]-, HER-2 negative breast cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- 31 Aug 2016 Biomarkers information updated
- 08 Aug 2012 Actual end date (1 May 2010) added as reported by ClinicalTrials.gov.
- 16 Jan 2008 The expected completion date for this trial is now 1 May 2010 as reported on ClinicalTrials.gov.